DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.
D000486:Allergy and Immunology; D000917:Antibody Formation; D000970:Antineoplastic Agents; D001327:Autoimmune Diseases; D003520:Cyclophosphamide; D005472:Fluorouracil; D007109:Immunity; D008357:Mannomustine; D015122:Mercaptopurine; D008727:Methotrexate; D051379:Mice; D009026:Mortality; D012106:Research; D013866:Thioguanine; D014116:Toxicology; D014180:Transplantation; D014265:Triethylenemelamine; D014436:Typhoid-Paratyphoid Vaccines; D014747:Vinblastine
D000970:Antineoplastic Agents; D014436:Typhoid-Paratyphoid Vaccines; D014747:Vinblastine; D003520:Cyclophosphamide; D008357:Mannomustine; D015122:Mercaptopurine; D014265:Triethylenemelamine; D013866:Thioguanine; D005472:Fluorouracil; D008727:Methotrexate
ANTIBODY FORMATION; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; EXPERIMENTAL LAB STUDY; FLUOROURACIL; IMMUNITY; IMMUNOLOGY; MANNOMUSTINE; MERCAPTOPURINE; METHOTREXATE; MICE; MORTALITY; THIOGUANINE; TOXICOLOGIC REPORT; TRANSPLANTATION; TRIETHYLENE MELAMINE; TYPHOID-PARATYPHOID VACCINES; VINBLASTINE